CNBC February 3, 2025
Annika Kim Constantino

Key Points

– President Donald Trump’s steep tariffs on Canada, Mexico and China could worsen exist­ing drug short­ages in the U.S. and raise health-care costs for patients, some drug trade groups warn.

– They also said the import taxes could strain cash-strapped generic drugmakers and distributors.

– Trump on Saturday announced he would impose a 25% tariff on nearly all goods shipped from Canada and Mexico and a 10% charge on imports from China.

President Donald Trump‘s steep tariffs on Canada, Mexico and China could worsen ex­ist­ing drug shortages in the U.S., raise health-care costs for patients and threaten cash-strapped generic drugmakers, some drug trade groups warn.

Trump on Saturday announced he would impose a 25% tariff on nearly...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
Three ways the Trump administration could reinvest in rural America's future, starting with health care
STAT+: Nobel laureates call on National Academies and biotech CEOs to speak out against Trump attacks on science
Congressional District Interactive Map: How Much Will ACA Premium Payments Rise if Enhanced Subsidies Expire?
Medical Device Makers Seek Exemption From Trump Tariffs
Bill introduced to reverse 2.83% physician Medicare cuts

Share This Article